GeoVax Labs Inc
GOVX0.530USD
-0.014-2.55%
交易中 （美東）報價延遲15分鐘
8.44M總市值
虧損本益比TTM
關於 GeoVax Labs Inc 公司
GeoVax Labs, Inc. 是一家臨牀階段的生物技術公司，利用專有平臺開發針對傳染病和實體瘤癌症的人類疫苗和免疫療法。其產品線包括正在進行的 Covid-19 疫苗人體臨牀試驗和針對晚期頭頸癌的基因導向療法。其其他研發項目包括針對 Mpox 和天花、出血熱病毒（埃博拉扎伊爾病毒、埃博拉蘇丹病毒和馬爾堡病毒）、寨卡病毒和瘧疾的預防性疫苗，以及針對多種實體瘤的免疫療法。該公司的全資、共同擁有和授權的知識產權組合包括 155 多項已授予或正在申請的專利申請，分佈在 24 個專利系列中。其候選產品包括 GEO-CM04S1、GEO-CM02、Gedeptin、MVA-VLP-MUC1、GEO-ZM02 等。其主要的傳染病候選藥物是 GEO-CM04S1，這是一種針對高危免疫功能低下患者羣體的 COVID-19 疫苗。
GeoVax Labs Inc簡介
公司代碼GOVX
公司名稱GeoVax Labs Inc
上市日期Apr 04, 1994
CEOMr. David A. Dodd
員工數量17
證券類型Ordinary Share
年結日Apr 04
公司地址1900 Lake Park Drive
城市SMYRNA
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編30080
電話16783847220
網址https://www.geovax.com/
公司代碼GOVX
上市日期Apr 04, 1994
CEOMr. David A. Dodd
GeoVax Labs Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. David A. Dodd
Mr. David A. Dodd
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
36.18K
-1.32%
Mr. Mark W. Reynolds, CPA
Mr. Mark W. Reynolds, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
14.01K
--
Mr. Dean G. Kollintzas
Mr. Dean G. Kollintzas
Independent Director
Independent Director
6.67K
+733.50%
Dr. Randal D. Chase, Ph.D.
Dr. Randal D. Chase, Ph.D.
Independent Director
Independent Director
6.67K
+173.17%
Dr. Robert T. McNally, Ph.D.
Dr. Robert T. McNally, Ph.D.
Independent Director
Independent Director
3.60K
--
Dr. Kelly T. Mckee, M.D.
Dr. Kelly T. Mckee, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jayne Morgan, M.D.
Dr. Jayne Morgan, M.D.
Independent Director
Independent Director
--
--
Dr. Mark J. Newman, Ph.D.
Dr. Mark J. Newman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. John N. (Jack) Spencer, Jr.
Mr. John N. (Jack) Spencer, Jr.
Independent Director
Independent Director
--
--
Dr. John W. Sharkey, Ph.D.
Dr. John W. Sharkey, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David A. Dodd
Mr. David A. Dodd
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
36.18K
-1.32%
Mr. Mark W. Reynolds, CPA
Mr. Mark W. Reynolds, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
14.01K
--
Mr. Dean G. Kollintzas
Mr. Dean G. Kollintzas
Independent Director
Independent Director
6.67K
+733.50%
Dr. Randal D. Chase, Ph.D.
Dr. Randal D. Chase, Ph.D.
Independent Director
Independent Director
6.67K
+173.17%
Dr. Robert T. McNally, Ph.D.
Dr. Robert T. McNally, Ph.D.
Independent Director
Independent Director
3.60K
--
Dr. Kelly T. Mckee, M.D.
Dr. Kelly T. Mckee, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月16日 週四
更新時間: 10月16日 週四
持股股東
股東類型
持股股東
持股股東
佔比
L1 Capital Global Opportunities Master Fund Ltd.
4.97%
The Vanguard Group, Inc.
0.39%
Geode Capital Management, L.L.C.
0.36%
UBS Switzerland AG
0.36%
UBS Financial Services, Inc.
0.31%
其他
93.61%
持股股東
持股股東
佔比
L1 Capital Global Opportunities Master Fund Ltd.
4.97%
The Vanguard Group, Inc.
0.39%
Geode Capital Management, L.L.C.
0.36%
UBS Switzerland AG
0.36%
UBS Financial Services, Inc.
0.31%
其他
93.61%
股東類型
持股股東
佔比
Corporation
4.97%
Investment Advisor
1.01%
Investment Advisor/Hedge Fund
0.46%
Bank and Trust
0.36%
Individual Investor
0.33%
Research Firm
0.03%
其他
92.85%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
41
552.39K
1.86%
-986.56K
2025Q2
48
1.26M
5.17%
+95.79K
2025Q1
48
1.22M
8.27%
+83.76K
2024Q4
47
829.80K
9.13%
+330.71K
2024Q3
46
493.58K
6.02%
-230.53K
2024Q2
44
230.87K
6.14%
-94.40K
2024Q1
48
277.50K
12.08%
-7.33K
2023Q4
47
235.03K
12.03%
+67.17K
2023Q3
51
129.03K
7.28%
-172.28K
2023Q2
50
129.35K
7.40%
-168.66K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
L1 Capital Global Opportunities Master Fund Ltd.
1.48M
4.97%
+1.48M
--
Jul 02, 2025
The Vanguard Group, Inc.
115.16K
0.39%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
106.95K
0.36%
+9.91K
+10.22%
Jun 30, 2025
UBS Switzerland AG
106.77K
0.36%
+29.13K
+37.52%
Jun 30, 2025
UBS Financial Services, Inc.
93.49K
0.31%
+79.65K
+575.62%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
50.12K
0.17%
-25.00K
-33.28%
Jun 30, 2025
Dodd (David A)
36.66K
0.24%
--
--
Jun 25, 2025
BlackRock Institutional Trust Company, N.A.
27.57K
0.09%
--
--
Jun 30, 2025
Spencer (John N Jr)
10.40K
0.07%
-1.00K
-8.77%
Jun 25, 2025
State Street Investment Management (US)
16.83K
0.06%
--
--
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
公告日期
類型
比率
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
